Trial intelligence / Profile preview

PRP and HA Combination in Knee Osteoarthritis

NCT03290365Completed

Sponsor
Tri-Service General Hospital
Start
Jan 2018
Primary completion
Jul 2021
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, double-blind trial of hyaluronic acid in knee osteoarthritis (OA) (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Severity of symptoms and functional status at 1 year. Started Jan 2018; status: completed.

02

Drugs

hyaluronic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03290365.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03290365.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call